2017
DOI: 10.1002/jlcr.3522
|View full text |Cite
|
Sign up to set email alerts
|

99mTc‐labeled NGR‐chlorambucil conjugate, 99mTc‐HYNICCLB‐c(NGR) for targeted chemotherapy and molecular imaging

Abstract: Targeted delivery of chemotherapeutic drug at the tumor site enhances the efficacy with minimum systemic exposure. Towards this, drugs conjugated with peptides having affinity towards a particular molecular target are recognized as affective agents for targeted chemotherapy. Thus, in the present study, tumor-homing asparagine-glycine-arginine (NGR) peptide ligand was conjugated to DNA alkylating nitrogen mustard, chlorambucil (CLB). The peptide-drug conjugate (PDC), CLB-c(NGR), was radiolabeled with Tc-HYNIC c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
17
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 12 publications
(17 citation statements)
references
References 25 publications
0
17
0
Order By: Relevance
“…Chlorambucil (CLB), a DNA-alkylating nitrogen mustard, is widely used to treat chronic lymphocytic leukemia, lymphomas, breast, and ovarian carcinoma and a variety of other solid tumors. To address the systemic toxicity and various other side effects caused by its low specificity, Vats K et al 41 explored the targeted chemotherapy ability of CLB-cNGR and used 99m Tc to monitor its pharmacokinetics and biodistribution through the chelator 6-hydra-zinonicotinic acid (HYNIC). Drugs conjugated with the targeting vectors NGR peptides can act as conduits for site-specific delivery and can then overcome the nonspecific accumulation in normal tissues.…”
Section: Monomeric Compounds Of Ngr For Tumor Radioimagingmentioning
confidence: 99%
“…Chlorambucil (CLB), a DNA-alkylating nitrogen mustard, is widely used to treat chronic lymphocytic leukemia, lymphomas, breast, and ovarian carcinoma and a variety of other solid tumors. To address the systemic toxicity and various other side effects caused by its low specificity, Vats K et al 41 explored the targeted chemotherapy ability of CLB-cNGR and used 99m Tc to monitor its pharmacokinetics and biodistribution through the chelator 6-hydra-zinonicotinic acid (HYNIC). Drugs conjugated with the targeting vectors NGR peptides can act as conduits for site-specific delivery and can then overcome the nonspecific accumulation in normal tissues.…”
Section: Monomeric Compounds Of Ngr For Tumor Radioimagingmentioning
confidence: 99%
“…A chemotherapeutic drug, chlorambucil (CLB), was conjugated to cCNGRC and functionalized with a HYNIC chelator for radiolabeling with 99m Tc. The targeted 99m Tc-HYNIC-CLB-cCNGRC probe inhibited cancer cell growth, and its high hydrophilicity promoted rapid clearance from nontarget organs [ 57 ]. In an attempt to change the pharmokinectic profile, a PEG2 linker was added to the structure, but no change was observed [ 58 ].…”
Section: Nonreactive Apn-targeting Agentsmentioning
confidence: 99%
“…The CD13 receptors specifically recognize asparagine–glycine–arginine (NGR) motif containing peptides . Radiometalated NGR peptide constructs are hence being explored as molecular imaging probes for detection and monitoring of CD13 receptor‐expressing malignant sites . According to a literature report, carboxyl terminal of cyclic NGR [cCNGRC] peptide is a favorable position for tagging radioisotopes/drugs rather than N‐terminal that plays more important role in receptor binding .…”
Section: Introductionmentioning
confidence: 99%
“…Radiometalation of NGR peptides has been reported with 64 Cu, 68 Ga, and 99m Tc for diagnostic purpose . However, single‐photon emission computed tomography (SPECT) radioisotope, 99m Tc has wider coverage in nuclear medicine hospitals because of lower infrastructure and financial requirement in comparison with positron emission tomography (PET) isotopes, 64 Cu and 68 Ga .…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation